Temporally resolved direct delivery of second messengers into cells using nanostraws by Xu, Alexander M. et al.
Lab on a Chip
TECHNICAL INNOVATION
Cite this: Lab Chip, 2016, 16, 2434
Received 7th April 2016,
Accepted 1st June 2016
DOI: 10.1039/c6lc00463f
www.rsc.org/loc
Temporally resolved direct delivery of second
messengers into cells using nanostraws†
Alexander M. Xu,ab Sally A. Kim,c Derek S. Wang,a
Amin Aalipoura and Nicholas A. Melosh*a
Second messengers are biomolecules with the critical role of conveying information to intracellular targets.
They are typically membrane-impermeable and only enter cells through tightly regulated transporters. Cur-
rent methods for manipulating second messengers in cells require preparation of modified cell lines or sig-
nificant disruptions in cell function, especially at the cell membrane. Here we demonstrate that 100 nm di-
ameter ‘nanostraws’ penetrate the cell membrane to directly modulate second messenger concentrations
within cells. Nanostraws are hollow vertical nanowires that provide a fluidic conduit into cells to allow
time-resolved delivery of the signaling ion Ca2+ without chemical permeabilization or genetic modification,
minimizing cell perturbation. By integrating the nanostraw platform into a microfluidic device, we demon-
strate coordinated delivery of Ca2+ ions into hundreds of cells at the time scale of several seconds with the
ability to deliver complex signal patterns, such as oscillations over time. The diffusive nature of nanostraw
delivery gives the platform unique versatility, opening the possibility for time-resolved delivery of any freely
diffusing molecules.
Introduction
Manipulating biological signaling cascades is an essential tool
in understanding disease,1,2 drug development,3 and funda-
mental biology.4–6 Signaling cascades are initiated by extracel-
lular molecules binding to receptor proteins at the cell mem-
brane,7 followed by rapid release of soluble secondary
messengers. These bind to downstream intracellular proteins
leading to changes in gene expression, protein translation,
and phenotypic outcomes8 and are thus critical to biotechnol-
ogy and pharmaceutical development. Significant research
has gone into finding biological or chemical means to manip-
ulate signaling cascades due to the difficulty of delivering
these species across the cell membrane.9,10 However, current
methods, including gene modification,11,12 optogenetics,13
chemical genetics,14–16 and molecular cages,17–19 are limited
due to off-target effects, difficulty in isolating a single control
gene, poor temporal resolution, limited cargos, and
photodamage.
With the recent advent of cell-penetrating
nanostructures,20–23 it may now be possible to transport the
components of biological signaling cascades directly through
the cell membrane, obviating the need for gene alteration or
chemical perturbations. These cell penetrating structures
have been shown to change certain cell behaviors and mor-
phology without preventing migration or proliferation or al-
tering transcription levels.27–29 Here we demonstrate for the
first time that cell-penetrating “nanostraws” provide direct,
temporal control of a membrane-impermeant second mes-
senger, Ca2+. The platform consists of 100 nm diameter hol-
low nanotubes that penetrate through the cell membrane
with minimal perturbation, providing a long-term conduit
into the cell cytoplasm (Fig. 1). Unlike solid-core nanowires
coated with molecular delivery agents, the nanostraws allow
temporal modulation of the materials through a micro-
fluidically coupled backplane.23,30–32 This technique is highly
advantageous in that it provides delivery of arbitrary second
messengers, small molecules, or proteins using the same
platform.
For highly dynamic second messengers, it is important to
show sharp on/off signal contrast and deliver material on the
time scale of seconds.24,25 Microchips have demonstrated
promise to this end by incorporating microfluidic valves and
switching,26 while nanoscale methods reduce sample vol-
umes to further improve temporal switching resolution and
delivery speed. However, the temporal requirement restricts
the use of certain nanoscale techniques such as electropora-
tion38 and nanoparticles,39 which are better suited to deliver
biomolecules such as nucleic acids and proteins. On the
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other hand, Ca2+ ions are one of the most physiologically sig-
nificant second messengers,33,34 with high diffusivity35 and
fluorescent indicators that are robust and well-character-
ized.36,37 Using the nanostraw platform, we deliver Ca2+ di-
rectly into cells and further control the delivery to oscillate
temporally, as indicated by two different reporters. Ulti-
mately, this technique could be used to address any stage of
a signaling network where the messenger is soluble and
freely diffusing.
Experimental
Nanostraw membrane fabrication
Nanostraws were fabricated as previously described23,30 using
100 nm pore diameter track etched polycarbonate mem-
branes as the template at a pore density of 3 × 107 pores per
cm2. Membrane templates for nanostraws were custom-
ordered from GVS (formerly Maine Manufacturing, Sanford,
ME). ALD was performed on the Savannah platform (Cam-
bridge Nanotech, Waltham, MA). A conformal 15 nm coating
of Al2O3 was applied to all surfaces of the template by
performing atomic layer deposition (ALD). Alumina ALD con-
sists of alternating cycles of trimethylaluminum (TMA) and
water (H2O) exposure with pulse lengths of 0.015 s of precur-
sor, 30 s of exposure, and 60 s of purging to ensure that the
precursors coated the entire length of the nanoporous mem-
brane with a 15 nm coating of Al2O3. Nanostraws were cre-
ated by etching the upper alumina surface using a
PlasmaQuest etcher and BCl3 and Cl2 plasma and removing
some of the polycarbonate template to expose the nanostraws
with oxygen plasma treatment using a SPI Plasma Prep III
Solid State. Typical nanostraw dimensions were 100 nm in di-
ameter and 1.5 μm in height.
Microfluidic device assembly
The nanostraw device consisted of a poly-dimethyl-siloxane
elastomer (PDMS) delivery channel, 100 μm deep and 0.5
mm wide, that contained the delivery solution, running be-
low the nanostraw membrane (Fig. 1). A second PDMS piece
containing the culture well and cells sealed above the nano-
straw membrane, so that the cargo diffused through the
nanostraws to enter the culture chamber. The top PDMS
piece also contained one or two inlet ports and an outlet for
access and temporal control of the delivery channel contents.
After assembling PDMS pieces, devices were sterilized in oxy-
gen plasma.
Cell culture, stable line preparation and calcium indicator
loading
Chinese hamster ovary (CHO) cells were obtained from Amer-
ican Type Culture Collection and were cultured in Dulbecco's
Modified Eagle Medium (DMEM) supplemented with 10% fe-
tal bovine serum and 100 U mL−1 penicillin/streptomycin un-
der standard culture conditions. Prior to cell plating, nano-
straw microfluidic devices were coated with 150 μM poly-L-
lysine or poly-ornithine overnight (>8 h) at 37 °C. CHO cells
were trypsinized and plated at 10 000 cells per device for
acute delivery and 100 000 cells per device for oscillating de-
livery. Delivery was recorded by flowing solutions through the
inlet ports and observing cells loaded with one of two re-
porters: GCaMP6s, a genetically encoded single fluorophore
calcium sensor protein,40 or Fluo-4 AM, a fluorescent chemi-
cal calcium indicator.41
A eukaryotic expression plasmid for GCaMP6s was gener-
ated by subcloning GCaMP6s (Addgene) into a lentiviral vec-
tor with an ubiquitin promoter (FUGWm). The resulting con-
struct (FU-GCaMP6s-Wm) was sequenced to verify the
cloning and final sequence. CHO cells were transfected with
the GCaMP6s plasmid using Lipofectamine 2000. After two
weeks of selection using 500 μg mL−1 G418 supplemented
media, GCaMP6s CHO cells were suspended in culture media
(∼2 mM Ca2+), and 1 μM ionomycin was added to the solu-
tion to increase the fluorescence of GCaMP6s-positive CHO
cells for cell sorting. GCaMP6s CHO cells were then sorted by
fluorescence activated cell sorting (FACS) for fluorescence
three orders of magnitude above background and were prop-
agated for Ca2+ delivery experiments. These cells were used
for acute delivery studies due to their consistent indicator
levels.
Fig. 1 Nanostraw microfluidic device schematic. Delivery solutions flow through the channel and diffuse into the cell culture chamber (5 mm
diameter) through the nanostraws (not drawn to scale). If a nanostraw penetrates into a cell, the delivery solution can enter the cell. Microfluidic
access enables delivery of soluble molecules to many cells positioned over the delivery channel and allows the solutions to be quickly exchanged.
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Fluo-4 AM was suspended in DMSO and 20% Pluronic
F127, and CHO cells were loaded with a final concentration
of 1 μM Fluo-4 AM in DMEM and 0.02% Pluronic F-127
(0.1% DMSO) for 30 min prior to Ca2+ delivery and imaging.
Fluo-4 is more readily available and does not require prior
cell modification as GCaMP6s does, but without the benefit
of prior cell sorting, the indicator levels are more variable
making it more suitable for slower, oscillatory signal mea-
surement. All cell culture and fluorescence dye reagents were
obtained from Invitrogen (Carlsbad, CA).
Microfluidic pumping and imaging
To perform Ca2+ delivery, cells were plated into microfluidic
devices for 24 h prior to imaging. Tyrode's solution (119 mM
NaCl, 2.5 mM KCl, 2 mM MgCl2, 2 mM CaCl2, 25 mM HEPES,
30 mM glucose) was used as the basis for delivery and imag-
ing solutions, and supplemented with 300 mM or 100 mM
Ca2+ for acute and oscillating delivery, respectively. Two sy-
ringe pumps (New Era Pump Systems, NE-1000) were at-
tached to the inlet ports with Tygon tubing, and Ca2+ solu-
tions were pumped into the inlets at a rate of 0.1 mL min−1,
which resulted in solution exchange in the channel volume
within 1 ms. For oscillating delivery, a syringe pump injected
Ca2+ solution for 30 s and turned off, upon which the second
syringe pump began injecting 100 mM EGTA solution until
the signal returned to near basal levels to complete each
oscillation.
Both acute delivery (GCaMP6s reporter) and oscillating de-
livery (Fluo-4 indicator) were imaged under the same condi-
tions. Wide-field epifluorescence imaging was performed
using an Axiovert 200 M inverted microscope (Zeiss) with a
10×/0.3 NA objective (Zeiss, EC Plan-Neofluar) using a Rolera
EM-C2 EMCCD camera with an image capture rate of 1 frame
per s. Fluorescence filter set 10 (Zeiss, 450-490 Excitation,
515-565 Emission) was used with an X-Cite 120Q excitation
light source. Images were processed by and analyzed using
ImageJ. For acute delivery, total cell counts were determined
by counting fluorescent cells after long term Ca2+ exposure
(Movies S1 and S2†). Following background subtraction and
alignment, average cell intensity was measured and plotted.
Results and discussion
To demonstrate one-time Ca2+ delivery into cells, GCaMP6s
CHO cells were plated at low density onto the nanostraw de-
vice. Previous studies have shown that cells cultured on
nanostraws remain viable and minimally perturbed for an ex-
tended period of time.23,30 In this study, the cells remained
viable and responsive to the Ca2+ pulse 24 hours after plating
(Fig. 2a), and the fluorescence response was imaged for cells
cultured on nanostraw membranes and flat membranes
(Fig. 2b). The initial Ca2+ response within the first 5 s shows
concerted and near-universal cellular delivery of Ca2+ on
nanostraws compared to the infrequent response rate ob-
served in cells on flat membranes (Fig. 2c). The initial rise in
intracellular Ca2+ reported by the GCaMP6s indicator was ob-
served within 1 s after delivery on nanostraws (N = 138). In
the first 5 s, ∼90% of nanostraw-delivered cells exhibited a
response (ΔF/F > 0.5), while <5% of cells on the flat mem-
brane exhibited an equivalent response (N = 217). This differ-
ence indicates that nanostraws facilitated a rapid and con-
certed flux of Ca2+ into the cytoplasm of cells.
When the Ca2+ signal was sustained in the delivery chan-
nel for longer than 5 s, the cells on the nanostraws
maintained a near-constant level of fluorescence with some
Fig. 2 One-time Ca2+ delivery using nanostraws. (a) CHO cells with Ca2+ indicators were plated onto nanostraw devices under two conditions (b):
cells on nanostraws and cells on a flat membrane with the same pore density without nanostraws. (c) For one-time delivery, a 300 mM Ca2+ pulse
was added, and cells were imaged before delivery and 1 s and 5 s after delivery. (d) A plot of the change in fluorescence over initial fluorescence
(ΔF/F) observed in each cell (gray lines) and the average (black line with standard deviation) demonstrates that nanostraws facilitate second mes-
senger delivery while the flat membrane does not.
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minor variation (Fig. 2d, Movie S1 in the ESI,† 20× speed). In
contrast, as the Ca2+ signal was sustained on the flat mem-
brane without nanostraws, some additional delivery events
were observed, but they were rare and sporadic for up to 90
s, after which fluorescence was observed across all cells
(Fig. 2d, Movie S2† 20× speed). While a coordinated Ca2+ re-
sponse was eventually observed in both conditions, the flat
membrane condition demonstrates the time required for
cells to take up Ca2+ when it is being pumped into extracellu-
lar solution instead of directly into cells through nanostraws.
In addition to detecting one-time Ca2+ delivery using
nanostraws, a temporally oscillating Ca2+ signal was
presented to densely plated cells to demonstrate large scale
dynamic control over second messenger delivery by leverag-
ing the rapid diffusive exchange through nanostraws. The os-
cillatory signal consists of alternating flows of 100 mM of ei-
ther Ca2+ or the chelating agent EGTA in Tyrode's solution
presented to Fluo-4 loaded cells (Fig. 3a). In response to this
signal pattern, oscillating Ca2+ reporter fluorescence was ob-
served for 3–4 cycles (Fig. 3b and c, Movie S3,† 225× speed).
These results demonstrate that the nanostraws provide a con-
tinuous pipeline for delivery into cells, whose contents can
be rapidly exchanged. Cell fluorescence during the EGTA
phase of the oscillatory signal is reduced to levels comparable
to baseline fluorescence prior to Ca2+ delivery. The EGTA may
be actively diffusing into cells to chelate Ca2+ or its presence
in the delivery channel may simply reverse the concentration
gradient to induce Ca2+ to diffuse out of the cell after nano-
straw delivery.
We used lower levels of Ca2+ for oscillating signal delivery
than for one-time delivery to match the solubility limit of
EGTA and to ensure that the stoichiometry of Ca2+ to chelator
binding was not rate-limiting. The lower concentration pro-
duced smaller reporter signals and also resulted in slower re-
sponse times, as expected from diffusion dynamics. Cell-to-
cell differences were also more pronounced using Fluo-4 with
the oscillating signal compared to one-time delivery of ele-
vated Ca2+ to GCaMP6s cells, likely due to a combination of
inherent nanostraw delivery variation30 and varying Fluo-4
AM indicator loading levels compared to more uniform
GCaMP6s indicator levels in sorted cells. While perfusion
speeds were fast enough to exchange the entire volume in the
delivery channel in <1 s, edge effects were expected and ob-
served, perhaps resulting in non-uniform flow and further
slowing the response time after several cycles.
Conclusions
Here we have demonstrated the direct manipulation of the
second messenger Ca2+ without requiring the use of genetic
manipulation, chemical carriers, or cell permeabilizers. Ca2+
is one of the most ubiquitous and important second messen-
gers, and while a number of effective Ca2+ regulating tools
are available, demonstrating Ca2+ manipulation inside cells
is a powerful proof of concept towards the study of lesser
known second messengers for which alternative techniques
such as photo-uncaging or optogenetics are not an option.
On the nanostraws, the cells remained viable after 24 hours
of culture and responsive to the Ca2+ signal, be it a single
acute pulse or an oscillatory sequence. Previously, nanotech-
nology has been applied to increase the efficiency of tech-
niques such as electroporation.32,38 The nanostraws provide a
similar scaling effect to microinjection to apply a high degree
of cell access and delivery to large numbers of cells.30
Future studies using the nanostraw platform may involve
improving time resolution and delivery speeds or more quan-
titative assessment of delivery levels, as the precise flux of
molecules in the delivery channel into the cell relative to the
channel concentration is currently unknown. This proof-of-
concept study used several cell densities and bright indica-
tors to demonstrate a range of delivery conditions, but quan-
tification will require the use of ratiometric dyes. The current
time resolution of nanostraw delivery matches Ca2+ signaling
dynamics in motility and transcription and as the time reso-
lution capabilities of nanostraw delivery increase, faster sig-
naling phenomena in neurons and the immune system can
be brought into focus.34 While Ca2+ is notable for the quality
of its reporters,36,37,40 other important signaling ions such as
Fig. 3 Oscillating Ca2+ delivery using nanostraws. (a) CHO cells with
Ca2+ indicators were plated on nanostraw devices and alternating
flows of 100 mM Ca2+ and EGTA were added to the delivery channel.
(b) Individual ΔF/F signals per cell and the average were plotted,
demonstrating that nanostraws can facilitate the delivery of oscillating
cycles of second messengers into cells. (c) Images at timepoints (t1–7)
corresponding to changes in delivery solution show three successful
cycles of Ca2+/EGTA before the cells begin to lose their coordinated
response to delivery.
Lab on a Chip Technical Innovation
Pu
bl
ish
ed
 o
n 
02
 Ju
ne
 2
01
6.
 D
ow
nl
oa
de
d 
by
 C
al
ifo
rn
ia
 In
sti
tu
te
 o
f T
ec
hn
ol
og
y 
on
 2
2/
07
/2
01
6 
16
:1
4:
48
. 
View Article Online
2438 | Lab Chip, 2016, 16, 2434–2439 This journal is © The Royal Society of Chemistry 2016
Zn2+ are also candidates for study42 as they are generally less
promiscuous than Ca2+. Beyond ionic signaling, time-
resolved signaling spans many orders of magnitude.43 Nano-
straws are uniquely poised to study this entire range of phe-
nomena, as long as the messengers are soluble and mobile
in solution. In conclusion, nanostraws are a powerful, generic
method to explore questions in second messenger signaling
and future applications of time-resolved intracellular delivery.
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